SCR-LIP-000476 · Claim · machine-readable JSON →

This review reports that lipedema onset or exacerbation occurs during hormonal transition periods (puberty, pregnancy, menopause, hysterectomy/oophorectomy) with estrogen receptor imbalance (ER-alpha suppressed, ER-beta activated), and that it shows autosomal dominant or X-linked dominant inheritance with a family history in 16-64% of cases.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
2 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

20152024Lipedema: A Review of the Literature (2015) · consistentModern aspects of etiopathogenesis, diagnosis and treatment of lipedema [Современные аспекты этиопатогенеза, диагностики и лечения липедемы] (2024) · consistent

Evidence (2)

Context (PECO)

Populationwomen with lipedema
Conditionlipedema
Exposurehormonal transition periods and hereditary/genetic factors
Outcomeonset/exacerbation of lipedema
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log